z-logo
open-access-imgOpen Access
Azithromycin for Prevention of Exacerbations of COPD
Author(s) -
Richard Albert,
John E. Connett,
William C. Bailey,
Richard Casaburi,
John A. Cooper,
Gerard J. Criner,
Jeffrey L. Curtis,
Mark T. Dransfield,
MeiLan K. Han,
Stephen C. Lazarus,
Barry J. Make,
Nathaniel Marchetti,
Fernando J. Martínez,
Nancy Madinger,
Charlene McEvoy,
Dennis E. Niewoehner,
Janos Porsasz,
Connie Price,
John J. Reilly,
Paul D. Scanlon,
Frank C. Sciurba,
Steven M. Scharf,
George R. Washko,
Prescott G. Woodruff,
Nicholas R. Anthonisen
Publication year - 2011
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1104623
Subject(s) - medicine , azithromycin , exacerbation , placebo , copd , confidence interval , randomized controlled trial , hazard ratio , antibiotics , alternative medicine , pathology , microbiology and biotechnology , biology
Acute exacerbations adversely affect patients with chronic obstructive pulmonary disease (COPD). Macrolide antibiotics benefit patients with a variety of inflammatory airway diseases.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom